LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
Clinical trial NCT02040870 · COMPLETED
Trial details
- NCT number
- NCT02040870
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-07
- Primary completion
- 2017-07-27
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.